Amgen Inc. (AMGN) Q4 2016 Earnings Results

Amgen Beats on EPS, Stock Down 0.06%

Amgen's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock experienced a slight decline of 0.06%, suggesting that investors may have been looking for more comprehensive guidance or additional insights into future performance. The lack of revenue data and guidance may have contributed to the muted stock reaction.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$2.89	N/A	+4.26%

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to shareholder value. However, no specific guidance was provided for future performance.

We are pleased with our EPS performance this quarter.

Our focus remains on delivering value to our shareholders.

Amgen Beats on EPS, Stock Down 0.06%

Key numbers

Management commentary

Amgen Inc.

More earnings this week

Amgen Beats on EPS, Stock Down 0.06%

Key numbers

Management commentary